Skip to content

COLL

Collegium Pharmaceutical, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$23.68
−0.08%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-27.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 10, 2026SANTINI GINO · directorM-Exempt8,700$16
May 20, 2026Freund John Gordon · directorSale20$34
May 18, 2026Balice-Gordon Rita J. · directorA-Award8,741$0.00
May 18, 2026Freund John Gordon · directorA-Award8,741$0.00
May 18, 2026BOHLIN GAREN G · directorA-Award8,741$0.00
May 18, 2026Lurker Nancy · directorA-Award8,741$0.00
May 18, 2026Glancy Donovan Michael · directorA-Award17,482$0.00
May 18, 2026Freund John Gordon · directorM-Exempt8,700$16
May 18, 2026Paya Carlos V · directorA-Award8,741$0.00
May 18, 2026Freund John Gordon · directorSale4,127$35
May 18, 2026SANTINI GINO · directorA-Award8,741$0.00
May 15, 2026Lurker Nancy · directorSale4,500$36
May 13, 2026BOHLIN GAREN G · directorSale8,700$37
May 13, 2026BOHLIN GAREN G · directorM-Exempt8,700$16
Apr 3, 2026Dieter David · officer: EVP & General CounselF-InKind8,840$36
Mar 20, 2026Dieter David · officer: EVP & General CounselSale13,976$35
Mar 5, 2026Dreyer Scott · officer: EVP & Chief Commercial OfficerSale46,417$40
Mar 5, 2026Dreyer Scott · officer: EVP & Chief Commercial OfficerSale3,559$41
Feb 12, 2026Dreyer Scott · officer: EVP & Chief Commercial OfficerA-Award30,702$0.00
Feb 12, 2026Smith Thomas B · officer: EVP and Chief Medical OfficerA-Award22,774$0.00
Feb 12, 2026Tupper Colleen · officer: EVP & Chief Financial OfficerF-InKind26,679$47
Feb 12, 2026Tupper Colleen · officer: EVP & Chief Financial OfficerA-Award26,421$0.00
Feb 12, 2026Karnani Vikram · director, officer: President and CEOA-Award79,264$0.00
Feb 12, 2026Dieter David · officer: EVP & General CounselA-Award22,194$0.00
Feb 12, 2026Tupper Colleen · officer: EVP & Chief Financial OfficerF-InKind11,861$47
Feb 12, 2026Tupper Colleen · officer: EVP & Chief Financial OfficerA-Award32,734$0.00
Feb 12, 2026Karnani Vikram · director, officer: President and CEOF-InKind11,296$47
Feb 12, 2026Dieter David · officer: EVP & General CounselA-Award9,005$0.00
Feb 12, 2026Smith Thomas B · officer: EVP and Chief Medical OfficerA-Award14,268$0.00
Feb 12, 2026Smith Thomas B · officer: EVP and Chief Medical OfficerF-InKind11,538$47
Institutional positioning

13F filings over the trailing two quarters

New 87Increased 230Reduced 166Sold out 29
FilerActionSharesFiled
BlackRock, Inc.Increased5,441,202Aug 7, 2026
BLACKROCK, INC.Increased5,134,027May 13, 2026
Jupiter Topco LLCNew Position2,147,072Aug 14, 2026
Invesco Ltd.Increased1,882,499Aug 14, 2026
JANUS HENDERSON GROUP PLCIncreased1,825,651May 18, 2026
FULLER & THALER ASSET MANAGEMENT, INC.Increased1,632,781Aug 12, 2026
PRINCIPAL FINANCIAL GROUP INCIncreased1,632,360Aug 4, 2026
INVESCO LTD.Increased1,591,909May 12, 2026
STATE STREET CORPIncreased1,528,881Aug 7, 2026
FULLER & THALER ASSET MANAGEMENT, INC.Reduced1,499,584May 14, 2026
RENAISSANCE TECHNOLOGIES LLCReduced1,469,449May 14, 2026
STATE STREET CORPIncreased1,424,544May 15, 2026
EVENTIDE ASSET MANAGEMENT, LLCReduced1,424,282May 15, 2026
MASSACHUSETTS FINANCIAL SERVICES CO /MA/Increased1,405,567Aug 3, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased1,381,261Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 10, 2026